Immuron Ltd has released a press release.
Travelan and Protectyn Are Now Available For Sale in China
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Immuron
- Travelan to Reach Upto 1.5M New US Customers via Magellans
- Immuron Rights Issue Offer Booklet (May 2016)
- Immuron Announces $6M Rights Issue Offer
- NASH Phase II Trial Reaches 50% Recruitment Milestone
- Immuron Announces E-Commerce Agreement with QBID in China
Later from Immuron
- IMC Signs Shigella Vaccine Developmt Agreement with US Army
- Immuron to repay outstanding Convertible Note in cash
- Immuron to Cooperate with Universities on Autism Research
- Travelan to be Stocked by US Distributor Medique Products
- US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron